James Mackin
Vermögen: 18 Mio $ am 31.05.2026
Vermögen: 18 Mio $ am 31.05.2026
Mr. James P.
Mackin is a Chairman, President & Chief Executive Officer at Artivion, Inc. and a President & Director at On-X Life Technologies, Inc. He is on the Board of Directors at Artivion UK Ltd. and On-X Life Technologies, Inc. Mr. Mackin was previously employed as an Independent Non-Executive Director by Wright Medical Group NV, an Independent Director by OpSens, Inc., a President by Cardiac Rhythm Management, a Vice President- Vascular, Western Europe by Medtronic, Inc., a Senior Vice President & General Manager by Genzyme Biosurgery Corp., and a Senior VP & Director-Sales Surgical Products by Genzyme, Inc. He received his undergraduate degree from US Military Academy and an MBA from Kellogg School of Management.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ARTIVION, INC. 1,71 % | 16.03.2026 | 830.743 ( 1,71 % ) | 18 Mio $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| ARTIVION, INC. | Vorstandsvorsitzender | 02.09.2014 |
CryoLife Europa Ltd.
CryoLife Europa Ltd. Medical DistributorsDistribution Services Sells and distributes medical devices | Direktor/Vorstandsmitglied | - |
On-X Life Technologies, Inc.
On-X Life Technologies, Inc. Medical SpecialtiesHealth Technology Develops, manufactures, and markets heart valve replacements | Präsident | - |
| Unternehmen | Position | Ende |
|---|---|---|
| OPSENS INC. | Direktor/Vorstandsmitglied | 01.12.2023 |
| WRIGHT MEDICAL GROUP N.V. | Direktor/Vorstandsmitglied | 11.11.2020 |
Cardiac Rhythm Management
Cardiac Rhythm Management Medical SpecialtiesHealth Technology Manufactures implantable devices to treat arrhythmias | Präsident | 01.08.2014 |
Medtronic, Inc.
Medtronic, Inc. Medical SpecialtiesHealth Technology Manufactures medical devices for hypertension care | Corporate Officer/Principal | 01.07.2014 |
Genzyme Biosurgery Corp.
Genzyme Biosurgery Corp. BiotechnologyHealth Technology Develops and manufactures biotherapeutic and biomaterial products | Corporate Officer/Principal | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 11 |
|---|---|
Medtronic, Inc.
Medtronic, Inc. Medical SpecialtiesHealth Technology Manufactures medical devices for hypertension care | Health Technology |
Artivion, Inc.
Artivion, Inc. Medical SpecialtiesHealth Technology Provides cryopreserved human tissue for vascular transplant applications | Health Technology |
On-X Life Technologies, Inc.
On-X Life Technologies, Inc. Medical SpecialtiesHealth Technology Develops, manufactures, and markets heart valve replacements | Health Technology |
Genzyme Biosurgery Corp.
Genzyme Biosurgery Corp. BiotechnologyHealth Technology Develops and manufactures biotherapeutic and biomaterial products | Health Technology |
US Military Academy
US Military Academy Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
OpSens, Inc.
OpSens, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and markets blood and plasma management medical devices, software solutions and services | Health Technology |
Cardiac Rhythm Management
Cardiac Rhythm Management Medical SpecialtiesHealth Technology Manufactures implantable devices to treat arrhythmias | Health Technology |
CryoLife Europa Ltd.
CryoLife Europa Ltd. Medical DistributorsDistribution Services Sells and distributes medical devices | Distribution Services |
Kellogg School of Management
Kellogg School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Wright Medical Group NV
Wright Medical Group NV Medical SpecialtiesHealth Technology Designs, manufactures and distributes orthopedic medical devices & biologic products | Health Technology |
Genzyme, Inc. |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen